Darrin Miles

Darrin Miles is the Chief Executive Officer of Nested Therapeutics. From his more than twenty years in the healthcare industry, Darrin brings invaluable experience in leading biotech program strategy and development and successfully overseeing novel cancer therapies through approval and commercial success. Prior to joining Nested, Darrin was the Chief Commercial Officer of Agios Pharmaceuticals, where he led the oncology and rare disease commercialization strategy and functions. While at Agios, he led the precision oncology program management function through the development and approval of IDHIFA® and TIBSOVO®, for the treatment of mutant IDH acute myeloid leukemia. His leadership at Agios was instrumental in developing company culture and expanding program leadership and commercial capabilities. Before Agios, he spent fourteen years at Genentech, taking on increasing responsibilities in global program leadership, marketing, sales management and market access to support a variety of brands including Rituxan®, Herceptin®, Tarceva® and Lucentis®. Darrin earned his B.S. in Applied Economics from Cornell University.